IPP Bureau
Dabur launches 'Dabur Himalayan Shilajit'
By IPP Bureau - July 26, 2022
Funds for R&D in drug discovery and manufacturing :PIB
By IPP Bureau - July 26, 2022
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
By IPP Bureau - July 25, 2022
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant at Changzhou site
By IPP Bureau - July 24, 2022
WuXi STA opens a new large scale continuous manufacturing plant
WuXi AppTec plans to build a new site in Singapore
By IPP Bureau - July 24, 2022
Better serving global partners and advancing healthcare innovation
FDA approval of deep brain stimulators will drive APAC market, says GlobalData
By IPP Bureau - July 24, 2022
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Import of Medical Devices Up by Record 41% in FY22: AiMeD
By IPP Bureau - July 24, 2022
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Merck opens microbiology application lab in Jigani, Bengaluru
By IPP Bureau - July 24, 2022
Merck’s first microbiology application and training lab in India
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
By IPP Bureau - July 24, 2022
With this, the company can start selling Ibuprofen in the European markets.
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
By IPP Bureau - July 24, 2022
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
DS-7300 Phase 2 Trial Initiated in Patients with Pretreated ExtensiveStage Small Cell Lung Cancer
By IPP Bureau - July 21, 2022
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Syngene reports revenue from operations up 8% in Q1 FY 23
By IPP Bureau - July 21, 2022
Company raises the annual revenue guidance from mid-teens to high teens
India’s first 4th Gen transcatheter mitral valve performed at Apollo Chennai
By IPP Bureau - July 21, 2022
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round
By IPP Bureau - July 20, 2022
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
